Intercellular crosstalk shapes purinergic metabolism and signaling in cancer cells

Julia Hesse1, Bodo Steckel2, Peter Dieterich3

  • 1Department of Molecular Cardiology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany; CARID, Cardiovascular Research Institute Düsseldorf, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.

Cell Reports
|January 4, 2024
PubMed

Insights

Adenosine metabolism varies by cancer type, influenced by ecto-adenosine deaminase (ADA) activity. This purine metabolism heterogeneity impacts anti-cancer immunity and may affect CD73 inhibitor efficacy.

Area of Science:

  • Biochemistry
  • Cancer Biology
  • Immunology

Background:

  • CD73 generates adenosine, suppressing anti-cancer immunity.
  • CD73 inhibitors are under clinical investigation for cancer therapy.

Purpose of the Study:

  • To investigate purine ectoenzyme kinetics across diverse cancer cell lines.
  • To understand how hypoxia and cancer type influence adenosine metabolism.
  • To correlate purine metabolism with immune cell interactions in the tumor microenvironment.

Main Methods:

  • Assessed enzyme kinetics of purinergic ectoenzymes in five cancer cell lines (Hodgkin lymphoma, multiple myeloma, pancreas adenocarcinoma, urinary bladder carcinoma, glioblastoma) under normoxia and hypoxia.
  • Combined enzyme kinetics data with single-cell RNA sequencing data from myeloma and glioblastoma tissues.
  • Analyzed purine metabolism heterogeneity across malignant, stromal, and immune cells.

Main Results:

  • Significant variation in adenosine metabolism was observed among different cancer types.
  • High ecto-adenosine deaminase (ADA) activity was prevalent across all tested cell lines, impacting adenosine accumulation kinetics.
  • Purine metabolism exhibited cancer type-specific spatial heterogeneity within the tumor microenvironment, differing between malignant, stromal, and immune cells.

Conclusions:

  • Adenosine metabolism is highly variable and cancer type-specific.
  • Ecto-adenosine deaminase (ADA) activity and spatial heterogeneity are critical factors influencing bioactive adenosine levels in the tumor microenvironment.
  • These findings have implications for the efficacy of CD73-targeted cancer immunotherapies.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
48.1K